DE69326840T2 - Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis - Google Patents

Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis

Info

Publication number
DE69326840T2
DE69326840T2 DE69326840T DE69326840T DE69326840T2 DE 69326840 T2 DE69326840 T2 DE 69326840T2 DE 69326840 T DE69326840 T DE 69326840T DE 69326840 T DE69326840 T DE 69326840T DE 69326840 T2 DE69326840 T2 DE 69326840T2
Authority
DE
Germany
Prior art keywords
compound
emedastine
treatment
allergic conjunctivitis
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69326840T
Other languages
German (de)
English (en)
Other versions
DE69326840D1 (de
Inventor
Shigetoshi Okumura
Stella Robertson
Tadayuki Saito
Hitoshi Tanaka
John Yanni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of DE69326840D1 publication Critical patent/DE69326840D1/de
Application granted granted Critical
Publication of DE69326840T2 publication Critical patent/DE69326840T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69326840T 1992-12-09 1993-12-08 Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis Expired - Lifetime DE69326840T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32921692A JP3527256B2 (ja) 1992-12-09 1992-12-09 抗アレルギー点眼剤
PCT/US1993/011939 WO1994013299A1 (en) 1992-12-09 1993-12-08 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis

Publications (2)

Publication Number Publication Date
DE69326840D1 DE69326840D1 (de) 1999-11-25
DE69326840T2 true DE69326840T2 (de) 2000-04-20

Family

ID=18218955

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326840T Expired - Lifetime DE69326840T2 (de) 1992-12-09 1993-12-08 Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis

Country Status (13)

Country Link
US (1) US5441958A (enExample)
EP (1) EP0673250B1 (enExample)
JP (1) JP3527256B2 (enExample)
KR (1) KR100275016B1 (enExample)
AT (1) ATE185696T1 (enExample)
AU (1) AU667613B2 (enExample)
CA (1) CA2151385C (enExample)
DE (1) DE69326840T2 (enExample)
DK (1) DK0673250T3 (enExample)
ES (1) ES2137352T3 (enExample)
GR (1) GR3032264T3 (enExample)
TW (1) TW257676B (enExample)
WO (1) WO1994013299A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2731618B1 (fr) * 1995-03-14 1997-08-01 Esteve Labor Dr Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
US6375973B2 (en) 2000-01-25 2002-04-23 Alcon Universal Ltd. Ophthalmic anti-allergy compositions suitable for use with contact lenses
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
JP2002249445A (ja) * 2000-12-19 2002-09-06 Ophtecs Corp 眼科用液剤組成物
US20040242638A1 (en) * 2001-12-05 2004-12-02 Yanni John M Use of an h1 antagonist and a safe steroid to treat rhinitis
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
WO2014006365A1 (en) 2012-07-04 2014-01-09 Dyson Technology Limited Attachment for a hand held appliance
GB2503687B (en) 2012-07-04 2018-02-21 Dyson Technology Ltd An attachment for a hand held appliance
EA202091725A1 (ru) 2018-01-18 2020-10-12 Фаэс Фарма С.А. Офтальмические композиции, содержащие биластин, бета-циклодекстрин и по крайней мере одно желатинирующее вещество

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPH0383924A (ja) * 1989-08-28 1991-04-09 Kanebo Ltd 経皮投与用組成物
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines

Also Published As

Publication number Publication date
HK1013964A1 (en) 1999-09-17
ES2137352T3 (es) 1999-12-16
US5441958A (en) 1995-08-15
DK0673250T3 (da) 1999-12-27
AU667613B2 (en) 1996-03-28
JPH06172179A (ja) 1994-06-21
EP0673250A1 (en) 1995-09-27
ATE185696T1 (de) 1999-11-15
CA2151385C (en) 1999-02-09
GR3032264T3 (en) 2000-04-27
KR100275016B1 (ko) 2000-12-15
DE69326840D1 (de) 1999-11-25
JP3527256B2 (ja) 2004-05-17
WO1994013299A1 (en) 1994-06-23
EP0673250B1 (en) 1999-10-20
AU5744294A (en) 1994-07-04
TW257676B (enExample) 1995-09-21
KR940013505A (ko) 1994-07-15
CA2151385A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
DE69634414T2 (de) Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie
DE69622527T2 (de) Formulierung zur topischen anwendung am auge, die olopatadine enthalten, zur behandlung von allergischen augenerkrankungen
DE60118859T2 (de) Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung
DE69530594T2 (de) Verfahren und mittel zur arzneistoffverabreichung
DE60101265T2 (de) Behandlung von augenschmerzen
DE69326610T2 (de) Arzneimittel gegen glaukom
DE69630325T2 (de) Nervenschutzende für Auge von Säugern unter Anwendung von Kaliumkanalblockern
DE602004005617T2 (de) Mittel zur behandlung von glaukomatöser retinopathie und optischer neuropathie
DE69534339T2 (de) Behandlung von normaldruckglaukom mit valsartan
DE3119051A1 (de) Mittel zur behandlung der augen
DE69326840T2 (de) Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis
DE69114470T2 (de) Komposition für die behandlung von augenschmerzen.
DE2918799A1 (de) Ophthalmische loesung
DE69501359T2 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE3850778T2 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE69614907T2 (de) Verwendung von einem CGRP Antagonist für die Behandlung von Augen oder Augenlidpruritus und Dysesthesien
DE60132325T2 (de) Ophthalmische lösung
DE3330053C2 (enExample)
DE69819900T2 (de) Wässrige flüssige pharmazeutische zusammensetzung enthaltend ein benzopyranderivat als hauptbestandteil
DE69028877T2 (de) Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden
US5668133A (en) Ophthalmic compositions comprising emedastine and methods for their use
DE69229688C5 (de) Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten
DE69033587T2 (de) Topische behandlung von blepharitis
DE69013431T2 (de) Anthocyanidine zur Behandlung von Augenkrankheiten.
EP0585896A1 (de) Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks

Legal Events

Date Code Title Description
8364 No opposition during term of opposition